When will the FDA reclassify BPC 157 to Category 1 Octagon AI Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to BPC 157: Miracle Healing Peptide or Hidden Danger? A Note on Peptides by Shantanu Out of Singapore FDA's Overreach on Compounded Peptides FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida